Catheter-related thrombosis: A practical approach

Journal of the Intensive Care Society

Volumn 17, Issue 2, 2016, Pages 160-167

  Wall, Caroline ^a   Moore, John ^a   Thachil, Jecko ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

anticoagulation; Catheter related thrombosis; central venous catheter; peripherally inserted central catheter; venous thromboembolism

Indexed keywords

WARFARIN;

CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; ERYTHEMA; EVIDENCE BASED PRACTICE; HEADACHE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERCOAGULABILITY; JUGULAR VEIN; KIDNEY FAILURE; PHLEBITIS; REVIEW; RISK FACTOR; SEPSIS; SHOULDER PAIN; SUPERIOR CAVA VEIN; SUPERIOR CAVA VEIN SYNDROME; SWELLING; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

EID: 84964861880     PISSN: 17511437     EISSN: None     Source Type: Journal    
DOI: 10.1177/1751143715618683     Document Type: Review

References (37)

1. P.W.KamphuisenA.Y.Lee. Catheter-related thrombosis: lifeline or a pain in the neck?Hematology Am Soc Haematol Educ Program2012; 2012: 638–644.
2. M.VersoG.J.Agnelli. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol2003; 21: 3665–3675.
3. P.DebourdeauD.FargeM.Beckers. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost2013; 11: 71–80.
4. S.J.FletcherA.R.Bodenham. Safe placement of central venous catheters: where should the tip of the catheter lie?Br J Anaesth2000; 85: 188–191.
5. R.TanD.KnowlesC.Streater. The use of peripherally inserted central catheters in intensive care: should you pick the PICC?J Intensive Care Med2009; 10: 95–98.
6. M.PittirutiA.BruttiD.Celentano. Clinical experience with power-injectable PICCs in intensive care patients. Crit Care2012; 16: R21.
7. N.FallouhH.M.McGuirkS.A.Flanders. Peripherally inserted central catheter – associated deep vein thrombosis: a narrative review. Am J Med2015; 128: 722–738.
8. M.BonizzoliS.BatacchiG.Cianchi. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med2011; 37: 284–289.
9. S.TrerotolaS.StavropoulosJ.Mondschein. Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation. Radiology2010; 256: 312–320.
10. V.ZochiosI.UmarN.Simpson. Peripherally inserted central catheter (PICC)-related thrombosis in critically ill patients. J Vasc Access2014; 15: 329–337.
11. V.ChopraD.RatzL.Kuhn. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost2014; 12: 847–854.
12. T.K.LiemK.E.YanitS.E.Moseley. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg2012; 55: 761–767.
13. C.J.Van RoodenM.E.TesselaarS.Osanto. Deep vein thrombosis associated with central venous catheters – a review. J Thromb Haemost2005; 3: 2409–2419.
14. J.BaskinC.H.PuiU.Reiss. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet2009; 374: 159–169.
15. D.J.Kuter. Thrombotic complications of central venous catheters in cancer patients. Oncologist2004; 9: 207–221.
16. S.L.WerlinT.LaustenS.Jessen. Treatment of central venous catheter occlusions with ethanol and hydrochloric acid. JPEN J Parenter Enteral Nutr1995; 19: 416–418.
17. B.J.HolcombeS.Forloines-LynnL.W.Garmhausen. Restoring patency of long-term central venous access devices. J Intraven Nurs1992; 15: 36–41.
18. J.MurrayE.PreciousR.Alikhan. Catheter-related thrombosis in cancer patients. Br J Haematol2013; 162: 748–757.
19. S.R.DeitcherM.R.FesenP.M.Kiproff. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol2002; 20: 317–324.
20. M.Di NisioG.L.Van SluidP.M.Bossuyt. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost2010; 8: 684–692.
21. M.L.Linenberger. Catheter related thrombosis: risks, diagnosis, and management. J Natl Compr Canc Netw2006; 4: 889–901.
22. M.SohneM.J.KruipM.Nijkeuter. Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism. J Thromb Haemost2006; 4: 1042–1046.
23. C.KearonS.KahnG.Agnelli. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest2008; 133: 454–545.
24. A.Y.LeeM.N.LevineR.I.Baker. for the Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med2003; 349: 146–153.
25. P.DebourdeauI.ElalamyA.De Raigniac. Long term use of daily subcutaneous low-molecular-weight heparin in cancer patients: why hesitate any longer?Support Care Cancer2008; 16: 1333–1341.
26. T.BaglinT.BarrowcliffeA.Cohen. Guidelines on the use and monitoring of heparin. Br J Haematol2006; 133: 19–34.
27. H.G.WatsonD.M.KeelingM.Laffan. Guidelines on aspects of cancer-related venous thrombosis. Br J Haematol2015; 170: 640–648.
28. L.BishopL.DoughertyA.Bodenham. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol2007; 29: 261–278.
29. S.KahnW.LimA.Dunn. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed. ACCP evidence-based clinical practice guidelines. Chest2012; 141: e195S–e226S.
30. M.M.BernJ.J.LokichS.R.Wallach. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med1990; 112: 423–428.
31. S.CoubanM.GoodyearM.Burnell. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol2005; 23: 4063–4069.
32. A.YoungL.BillinghamG.Begum. WARP Collaborative Group, UK (2009) Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet2009; 373: 567–574.
33. E.A.AklS.R.VasireddiS.Gunukula. Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev2011; 16: CD006468.
34. National Patient Safety Agency. Intravenous heparin flush solutions, www.nrls.npsa.nhs.uk/resources/?entryid45=59892 (2008, accessed 10 August 2015)
35. R.P.TullyB.A.McGrathJ.A.Moore. Observational study of the effect of heparin containing flush solutions on the incidence of arterial catheter occlusion. J Intensive Care Med2014; 15: 213–215.
36. E.López-BrizV.Ruiz GarciaJ.B.Cabello. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database Syst Rev2014; 10: CD008462.
37. M.D.MitchellB.J.AndersonK.Williams. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs2009; 65: 2007–2021.